Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 1;29(3):345-361.
doi: 10.5551/jat.61960. Epub 2021 Jan 22.

Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study

Affiliations

Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study

Takanori Honda et al. J Atheroscler Thromb. .

Abstract

Aim: To develop and validate a new risk prediction model for predicting the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in Japanese adults.

Methods: A total of 2,454 participants aged 40-84 years without a history of cardiovascular disease (CVD) were prospectively followed up for 24 years. An incident ASCVD event was defined as the first occurrence of coronary heart disease or atherothrombotic brain infarction. A Cox proportional hazards regression model was used to construct the prediction model. In addition, a simplified scoring system was translated from the developed prediction model. The model performance was evaluated using Harrell's C statistics, a calibration plot with the Greenwood-Nam-D'Agostino test, and a bootstrap validation procedure.

Results: During a median of a 24-year follow-up, 270 participants experienced the first ASCVD event. The predictors of the ASCVD events in the multivariable Cox model included age, sex, systolic blood pressure, diabetes, serum high-density lipoprotein cholesterol, serum low-density lipoprotein cholesterol, proteinuria, smoking habits, and regular exercise. The developed models exhibited good discrimination with negligible evidence of overfitting (Harrell's C statistics: 0.786 for the multivariable model and 0.789 for the simplified score) and good calibrations (the Greenwood-Nam-D'Agostino test: P=0.29 for the multivariable model, 0.52 for the simplified score).

Conclusion: We constructed a risk prediction model for the development of ASCVD in Japanese adults. This prediction model exhibits great potential as a tool for predicting the risk of ASCVD in clinical practice by enabling the identification of specific risk factors for ASCVD in individual patients.

Keywords: Atherosclerosis; Cardiovascular disease; Japanese; Prediction model; Risk factors.

PubMed Disclaimer

Figures

Supplemental Fig.1.
Supplemental Fig.1.
Flow chart of the study sample
Supplemental Fig.2. Selection rate of the candidate predictors in 200 bootstrapping samples
Supplemental Fig.2. Selection rate of the candidate predictors in 200 bootstrapping samples
The solid black bar indicates variables that selected for >40% (i.e., >80 times) of the bootstrapping resampling procedure. Abbreviations: HDL cholesterol, high-density lipoprotein cholesterol; LDL cholesterol, low-density lipoprotein cholesterol.
Fig.1. Simplified point-based scoring system for atherosclerotic cardiovascular disease
Fig.1. Simplified point-based scoring system for atherosclerotic cardiovascular disease
The predicted probability was determined using the following formula: P^ =1−0.9696 exp([total score+points for age]×0.144−2.4767) , where the points of 0, 5, 11, 16, and 20 for age were assigned to the age ranges of 40-49, 50-59, 60-69, 70-79, and ≥ 80 years, respectively. Probabilities are presented in green (low risk: <2.0% of the 10-year atherosclerotic cardiovascular disease risk, corresponding to the lowest 35% of the distribution in the population), yellow (middle risk: 2.0%–10.0%), and red (high risk: ≥ 10%, corresponding to the highest 20% of the distribution in the population). In the alternative simplified score that included serum non-HDL cholesterol instead of serum LDL cholesterol, the points for the predefined categories of serum non-HDL cholesterol (<150, 150–169, 170–189, and ≥ 190 mg/dL) were 0, 1, 2, and 3, respectively.
Supplemental Fig.3. Histogram of the 10-year ASCVD probabilities predicted by the simplified risk score
Supplemental Fig.3. Histogram of the 10-year ASCVD probabilities predicted by the simplified risk score
Bars were color-coded as green (low-risk: <2.0% of 10-year atherosclerotic cardiovascular disease risk, corresponding to the lowest 35% of distribution in the population), yellow (middle-risk: 2.0%–10.0%), and red (high-risk: ≥ 10%, corresponding to the highest 20% of distribution in the population)
Fig.2. Calibration plots of the predicted 10-year probability of atherosclerotic cardiovascular disease predicted by the multivariable model (A) and the simplified scoring system (B)
Fig.2. Calibration plots of the predicted 10-year probability of atherosclerotic cardiovascular disease predicted by the multivariable model (A) and the simplified scoring system (B)
The dotted lines indicate the case of perfect calibration, corresponding to an intercept of zero and a slope of one for the calibration plot. The solid curves indicate the calibration curve fit by the loess smoother. Bars indicate the 95% confidence intervals of the observed probability in each group of the predicted probability. Abbreviation: GND, Greenwood-Nam-D’Agostino.
Supplemental Fig.4.
Supplemental Fig.4.
Agreement between the final multivariable model using serum LDL cholesterol and the alternative model using serum non-HDL cholesterol as a predictor
Supplemental Fig.5.
Supplemental Fig.5.
Agreement between the simplified risk score using serum LDL cholesterol and the alternative simplified score using serum non-HDL cholesterol as a predictor

References

    1. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J, 2004; 25: 1197-1207 - PubMed
    1. Hoshino T, Sissani L, Labreuche J, Ducrocq G, Lavallée PC, Meseguer E, Guidoux C, Cabrejo L, Hobeanu C, Gongora-Rivera F, Touboul PJ, Gabriel Steg P, Amarenco P. Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol, 2018; 75: 203-211 - PMC - PubMed
    1. Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb, 2015; 22: 1287-1304 - PubMed
    1. Bhatt DL, Gabriel Steg P, Magnus Ohman E, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, Röther J, Wilson PWF. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, 2006; 295: 180-189 - PubMed
    1. Damen JAAG, Hooft L, Schuit E, Debray TPA, Collins GS, Tzoulaki I, Lassale CM, Siontis GCM, Chiocchia V, Roberts C, Schlüssel MM, Gerry S, Black JA, Heus P, Van Der Schouw YT, Peelen LM, Moons KGM. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ, 2016; 353: i2416 - PMC - PubMed